Alan V. Mateo
Board Member
10x Genomics, Inc. (TXG)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alan V. Mateo
Alan V. Mateo is recorded as Board Member at 10x Genomics, Inc. (TXG). 10x Genomics, Inc. reported in an 8-K filed June 20, 2024 that Alan V. Mateo was appointed Class II director, effective June 18, 2024.
“On June 18, 2024, upon the recommendation of its Nominating and Corporate Governance Committee, the Board of Directors of 10x Genomics, Inc. (the “Company”) appointed Alan V. Mateo to the Board of Directors as a Class II director effective immediately with a term expiring at the Company's 2027 annual meeting of stockholders or until his successor is duly elected and qualified or until his earlier death, resignation, disqualification or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-18–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at 10x Genomics, Inc.
Other people whose current roles at this company are on record from its filings.
- Serge Saxonov CEO, Board Member
- John R. Stuelpnagel Chairman, Board Member
- Adam S. Taich CFO
- Randy Wu General Counsel
- Alan Mateo Board Member
- Benjamin J. Hindson Board Member
- Kimberly J. Popovits Board Member
- Sarah A. Teichmann Board Member
- Sarah Teichmann Board Member
- Shehnaaz Suliman Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.